The model predicted 0% of HCC occurrence at 3 years in patients with score 0 (baseline LSV > 17.3 kPa, albumin > 4.2 g/dL, and 1-year DeltaLSV > 25.5%) versus 5.2% in patients with scores of 1–3. This evidence concerns the gene ALB and hepatocellular carcinoma.